TruBridge (TBRG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting will be held virtually on May 8, 2025, with voting on key proposals including director elections, board declassification, incentive plan amendments, executive compensation, and auditor ratification.
Stockholders can vote online, by phone, mail, or during the meeting, with a record date of March 14, 2025.
The board recommends voting in favor of all proposals and emphasizes environmental responsibility by holding a virtual meeting and providing proxy materials online.
Voting matters and shareholder proposals
Proposals include electing four directors, declassifying the board, amending the 2019 Incentive Plan, an advisory vote on executive compensation, and ratifying Grant Thornton LLP as auditor.
The board recommends voting FOR all proposals.
Approval of the Declassification Amendment will result in annual director elections starting in 2026.
Shareholder proposals for the 2026 meeting must be submitted by November 26, 2025.
Board of directors and corporate governance
The board is currently classified but seeks declassification for annual elections.
Recent cooperation agreements with major investors led to new director appointments.
7 of 9 directors are independent, with an independent chairperson.
Board committees include Audit, Compensation, Nominating and Corporate Governance, and Innovation and Technology.
Annual board and committee evaluations are conducted, with a focus on continuous improvement.
Stock ownership guidelines apply to directors and executive officers.
Latest events from TruBridge
- Margin gains, strong recurring revenue, and GAAP profitability marked the year.TBRG
Q4 202531 Mar 2026 - RCM gains and margin expansion offset EHR declines as full-year guidance is reaffirmed.TBRG
Q2 20242 Feb 2026 - RCM growth, offshoring, and analytics drive TruBridge's margin and operational focus.TBRG
Stifel 2024 Cross Sector Insight Conference1 Feb 2026 - Revenue and bookings rose, but net loss widened and internal control weaknesses persisted.TBRG
Q3 202415 Jan 2026 - Recurring revenue, offshoring, and automation drive growth and margin expansion into 2025.TBRG
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Margin gains, SaaS shift, and RCM growth drive a strong outlook in rural healthcare.TBRG
KeyBanc Annual Healthcare Forum 202526 Dec 2025 - 2024 revenue $339.2M, EBITDA up, leverage down, 2025 margin and revenue growth expected.TBRG
Q4 202424 Dec 2025 - Shareholders will vote on board declassification, incentive plan expansion, and executive pay.TBRG
Proxy Filing1 Dec 2025 - Key votes include board declassification, director elections, and incentive plan expansion.TBRG
Proxy Filing1 Dec 2025